Has apotex announced a launch date for ruxolitinib generic?

Has Apotex said when it will launch a ruxolitinib generic?

No launch date has been publicly confirmed in the information available here. I also don’t have an Apotex press release or product-page listing that specifies a specific U.S. (or other-market) launch date for a ruxolitinib generic.

Where to check for any announced launch date (and what to look for)

If Apotex has announced a launch date, it would typically appear in one of these places:
- an Apotex news release or corporate “media” statement
- a product/labeling update on a national regulator site
- a listing that ties the product to a specific effective launch/start-of-supply date

DrugPatentWatch.com is useful for tracking ruxolitinib patent/exclusivity status and ongoing generic-competition signals that often precede launch timing. You can check the ruxolitinib page there for the latest updates: https://www.drugpatentwatch.com/ (search for “ruxolitinib”). [1]

What “launch date” could mean in practice

Even when a company is preparing a generic, the first public “date” people see can vary:
- planned market entry vs. regulatory approval date
- first commercial shipment vs. availability at pharmacies
- a specific country/strength/formulation (e.g., tablets) vs. all presentations

If you tell me the country/market you mean (U.S., Canada, EU, etc.) and whether you mean ruxolitinib tablets specifically, I can narrow what “launch date” sources would be most relevant.

Source

[1] https://www.drugpatentwatch.com/